Daegu, South Korea

In Kyu Lee

This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Kyungpook National University Industry-Academic Cooperation Foundation, Novmetapharma Co., Ltd.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: In Kyu Lee. Retrieved from https://idiyas.com/inventor/in-kyu-lee-prmwbjik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: In Kyu Lee: Innovator in Pharmaceutical Compositions

Introduction

In Kyu Lee is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 6 patents. His work focuses on innovative solutions for health-related issues, particularly those involving hypercortisolemia and macular degeneration.

Latest Patents

One of his latest patents is a composition comprising thiamine derivatives for the prevention or treatment of hypercortisolemia. This invention relates to a composition that includes allithiamine, fursultiamine, and benfotiamine, which are derivatives of thiamine. The composition is designed to effectively treat or alleviate symptoms resulting from excessive secretion of cortisol, without the need for surgical operations, and it does not exhibit the side effects commonly associated with conventional medications.

Another significant patent is a composition for the prevention or treatment of macular degeneration. This pharmaceutical composition includes fursultiamine or a salt thereof, which has been shown to decrease the upregulated expression of HIF-1α in retinal pigment epithelial cells. It also suppresses the growth of choroidal vascular endothelial cells, making it a potential therapeutic agent for various neovascular ocular diseases.

Career Highlights

In Kyu Lee has worked with reputable institutions, including the Kyungpook National University Industry-Academic Cooperation Foundation and The Asan Foundation. His experience in these organizations has allowed him to further his research and development in the pharmaceutical field.

Collaborations

He has collaborated with notable colleagues such as Chang Joo Oh and Dong Ho Park, contributing to the advancement of innovative solutions in healthcare.

Conclusion

In Kyu Lee's contributions to pharmaceutical compositions demonstrate his commitment to addressing critical health issues through innovation. His patents reflect a dedication to improving treatment options for patients, showcasing the impact of his work in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…